Skin Cancer

>

Latest News

Pembrolizumab Outperforms Ipilimumab in 7-Year Follow-Up of Patients With Advanced Melanoma
Pembrolizumab Outperforms Ipilimumab in 7-Year Follow-Up of Patients With Advanced Melanoma

August 23rd 2023

At 85.3 months follow-up, the median overall survival with pembrolizumab was 32.7 months vs 15.9 months with ipilimumab.

melanoma
ASCO Updates Systemic Therapy Guidelines for Melanoma

August 17th 2023

FDA Approves Hepzato Kit for Metastatic Uveal Melanoma With Liver Metastases
FDA Approves Hepzato Kit for Metastatic Uveal Melanoma With Liver Metastases

August 15th 2023

Pills © Grycaj
Patients Are Concerned About Developing an Opioid Addiction Following Mohs Microscopic Surgery

August 1st 2023

FDA
Lifileucel Under Priority Review For Advanced Melanoma

July 1st 2023

Latest CME Events & Activities

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

2nd Annual International Congress on Pediatric Oncology

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

9th Annual School of Gastrointestinal Oncology® (SOGO®)

Register Now!

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

BURST CME™: What Is the Real Risk in Lower-Risk MDS?

View More

BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?

View More

BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS

View More

The Latest on Acute Lymphocytic Leukemia

View More

A Focus on Acute Myeloid Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma

View More

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Medical Crossfire®: Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

25th Annual International Lung Cancer Congress®

Register Now!

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Community Practice Connections™: Multidisciplinary Strategies for Improving Outcomes in CML from Frontline Care… and Beyond!

View More

Crucial Conversations in R/R Multiple Myeloma: Nursing Strategies to Optimize Patient Communication and Improve Outcomes

View More

Advances In™: Aligning Pathology and Oncology Efforts in the Community to Improve NSCLC Care

View More

GlobaOncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of B-Cell Lymphomas with BTK Inhibitors

View More

Myeloma Management Considerations: Applying the Evidence With Monoclonal Antibody Based Regimens

View More

More News

© 2023 MJH Life Sciences

All rights reserved.